NCIHA Press Release Regarding CBD and the FDA

Dear North Carolina Hemp Industry, On Friday I had an informative and engaging conversation with Joe Reardon, Assistant Commissioner of NC Department of Agriculture and Consumer Services, regarding recent reports of warning letters sent to Hemp/CBD processors across the state. I was relieved to know that North Carolina is trying to be assertive with an... Continue Reading →

North Carolina Based Hemp Bounces Back

Grown 2 Gold, LLC helps local cultivators battle back after Florence WILMINGTON, N.C. – November 21, 2018 /Canna Newswire/ –  Grown 2 Gold, LLC, which is a North Carolina based multi-level hemp company, has been working to help local cultivators salvage harvests from the massive devastation Hurricane Florence inflicted on this year’s crops. “We lost our entire... Continue Reading →

Epidiolex is rescheduled by the DEA to a class V

Kathy Young | AP GW Pharmaceuticals’ Epidiolex, a medicine made from marijuana, but without THC. The Drug Enforcement Administration has rescheduled Epidiolex, paving the way GW Pharmaceuticals to start selling the first FDA-approved drug that’s derived from cannabis, but stopping short of reclassifying all cannabidiol products. The Food and Drug Administration in June approved Epidiolex, which is derived from cannabidiol, or... Continue Reading →

Up ↑